Barclays
PIII icon

Barclays’s P3 Health Partners PIII Stock Holding History

Barclays’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-66
Closed -$590 – 5574
2025
Q3 		$590 Buy
+66
New +$498 ﹤0.01% 5198
2024
Q3 		– Sell
-352
Closed -$7.93K – 5432
2024
Q2 		$7.93K Sell
352
-232
-40% -$6.93K ﹤0.01% 4534
2024
Q1 		$30.1K Sell
584
-539
-48% -$29.9K ﹤0.01% 4700
2023
Q4 		$79.1K Buy
1,123
+979
+680% +$67.5K ﹤0.01% 4689
2023
Q3 		$10.6K Sell
144
-165
-53% -$17.1K ﹤0.01% 4292
2023
Q2 		$46.1K Buy
309
+69
+29% +$9.54K ﹤0.01% 3878
2023
Q1 		$12.7K Buy
240
+109
+83% +$6.55K ﹤0.01% 4716
2022
Q4 		$12K Buy
131
+110
+524% +$23.8K ﹤0.01% 4890
2022
Q3 		$5K Sell
21
-5
-19% -$1.25K ﹤0.01% 4504
2022
Q2 		$5K Buy
+26
New +$7.24K ﹤0.01% 4786

Other funds holding PIII

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
TFA
Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays's PIII Position: Q4 2025 in Review

Barclays sold out of P3 Health Partners (PIII) in Q4 2025, closing a stake of 66 shares — an estimated $590 sold.

Barclays first reported a position in PIII in Q2 2022 and held it in 10 quarters. The position peaked at $79.1K in Q4 2023. 13 funds tracked by Wall St. Rank hold PIII as of Q4 2025.

  • Barclays reported no remaining P3 Health Partners position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 66 P3 Health Partners shares in Q4 2025, an estimated $590.
  • Barclays first reported a position in P3 Health Partners in Q2 2022 and held it in 10 quarters.
  • Barclays's P3 Health Partners position peaked at $79.1K in Q4 2023.
  • 13 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.